When do semaglutide plateaus usually happen?
Most often around the one-year mark. In the STEP 1 trial, weight loss started by week 4 and kept going until it reached its lowest point at week 60. After that, the average held steady through week 68 at about 15% below the starting weight. The curve’s steepest stretch was the first six months; from about month nine onward, each month brought less.
So a slowdown after nine to twelve months is the expected shape, not a sign the drug stopped working. A plateau in the first few months is different and is more often about dose, eating or tolerance.
Why does the body push back as weight comes off?
Because a smaller body burns less, and sometimes less than its size predicts. Every pound lost lowers the energy needed to carry and maintain your body. On top of that, metabolism can slow beyond what the weight change explains.
The clearest example is a six-year follow-up of contestants from a televised weight-loss competition. Their resting metabolic rate fell by about 610 calories a day during the competition, and six years later it was still about 500 calories a day lower than expected for their size. That was extreme dieting rather than semaglutide, but it shows how strongly the body defends against loss.
How does low protein make a plateau worse?
It costs muscle, and muscle is the tissue that keeps your energy use up. A 2025 nutrition advisory on GLP-1 therapy warns that reduced appetite often leads to low protein intake and muscle loss. It notes that targets of 1.2 to 1.6 g per kilogram a day have been proposed during active weight loss, and that protein alone is unlikely to protect muscle without structured resistance training. Aerobic exercise alone does less to protect lean mass.
A man who has been eating one small meal a day for months may be at a plateau partly because he has lost more muscle than he needed to. That is why body composition, not just weight, is checked at a plateau visit. See muscle loss on semaglutide for more.
What gets reviewed at a plateau visit?
The goal is to find what has actually changed before changing anything. A typical review covers:
| Area | What gets checked |
|---|---|
| Dose | Current dose and whether it was ever reached; per the Wegovy label, maintenance is 1.7 or 2.4 mg, and 7.2 mg is an option after at least four weeks on 2.4 mg when more loss is clinically needed |
| Body composition | Whether fat is still falling while weight holds, which is a win, or muscle is slipping |
| Protein and meals | Grams per day, meal spacing, ultraprocessed snacks, alcohol |
| Training | Strength sessions per week and whether loads are progressing |
| Sleep and stress | Short sleep is linked with more hunger and insulin resistance |
| Labs | Thyroid, glucose, and testosterone where symptoms fit |
| Expectations | Whether the current weight is already a healthy, sustainable target |
The higher dose comes with trade-offs. The label reports altered skin sensations in 22% of people on 7.2 mg versus 6% on 2.4 mg, so it is not an automatic next step.
Related question: should I switch to tirzepatide?
Sometimes that is the right move, and sometimes the better fix is protein, training or simply accepting a healthy new set point. Our page on switching from semaglutide to tirzepatide explains how that decision is made, and weight loss plateaus in men covers stalls that happen without medication.
How Ultimate Male handles a plateau
At Ultimate Male, a plateau triggers a review instead of an automatic dose increase. Your PA-C or MD compares your current body composition analysis with earlier scans, looks at your eating and training log, and checks labs if anything points to thyroid, blood sugar or hormone issues.
The outcome might be a protein and lifting plan, a dose discussion, a medicine change, or a decision that you have reached a maintenance weight worth defending. If you are stuck on semaglutide, whether you started at our clinic or elsewhere, the medical weight loss team can take a fresh look. Call 626-319-5261 or book online.
